Skip to content
mapperlab
← Dashboard
Stock

CORZ

Core Scientific, Inc./tx
Latest close $248 of 27 marquee funds currently hold1 CUSIP mapped
Current holders
8
27 funds tracked
Ever held
10
Current + past
New this quarter
1
Exited this quarter
0

Marquee-fund ownership over time

Aug 9, 2024Feb 14, 2025Nov 14, 2025May 15, 2026
Now
8

This quarter's activity

New positions opened

Positions exited

None.

Current holders

Sorted by tenure (longest first)
FundEntry priceLatest closeReturn on entry
Renaissance Technologies$9.70$24+143%
Citadel Advisors$8.80$24+168%
Point72 Asset Management re-entered$8.80$24+168%
Two Sigma Investments$15$24+53%
AQR Capital Management$15$24+53%
D.E. Shaw$13$24+88%
Millennium Management re-entered$13$24+88%
Soros Fund Management$18$24+32%

“Return on entry” is the price-only move from the fund's first disclosure to today — it ignores any adds, trims, or dividends. A fund that built its position over multiple quarters has a true cost basis somewhere between entry price and latest close; this figure is the upper bound.

Past holders

Funds that exited at some point
FundEntry → ExitReturn
Third Point→ $17+15%
Bridgewater Associates→ $18+18%

Insider activity

Form 4 — officers, directors, 10%+ owners

Filed within two business days of each transaction by anyone with material insider status at Core Scientific, Inc./tx. Pair with the holders table above as a sanity check: heavy insider buying alongside marquee-fund accumulation is the strongest accumulation signal; heavy insider selling alongside fund exits is the strongest distribution signal.

Filings · last 30d
8
Filings · last 90d
19
Total on file
135
Recent SEC buffer
Most recent
Jun 3, 2026

30d / 90d windows measured from Jun 3, 2026 — the most recent Form 4 on file — not from today.

Showing 15 of 135 recent Form 4 filings. Browse all on EDGAR ↗

Fundamentals

XBRL · Core Scientific, Inc./tx

Annual figures sourced directly from Core Scientific, Inc./tx's 10-K / 10-Q filings via SEC EDGAR XBRL. Latest fiscal year and the year-over-year change, with up to ten years of history.

Revenue
$319.02M
FY2025-38% YoY
Net income
-$288.62M
FY2025+80% YoY
EPS (diluted)
$-0.8800
FY2025+82% YoY
Free cash flow(?)
-$450.75M
FY2025-500%+ YoY

Recent SEC filings

10-K · 10-Q · 8-K · 13D/G · proxy

The most recent material filings for Core Scientific, Inc./tx — earnings, material events, ownership disclosures, proxy statements. Form 4 insider activity is shown in the panel above.

Trade history

Every open→close lifecycle across tracked funds
FundOpen dateClose dateOpen priceClose price / currentReturn
Millennium ManagementQ2 2026open$24$24-3%
Point72 Asset ManagementQ1 2026open$17$24+37%
Soros Fund ManagementQ1 2026open$18$24+32%
Third PointQ4 2025Q1 2026$15$17+15%
Bridgewater AssociatesQ4 2025Q1 2026$15$18+18%
Point72 Asset ManagementQ2 2025Q4 2025$11$15+42%
D.E. ShawQ1 2025open$13$24+88%
Millennium ManagementQ1 2025Q3 2025$13$14+11%
Two Sigma InvestmentsQ4 2024open$15$24+53%
AQR Capital ManagementQ4 2024open$15$24+53%
Citadel AdvisorsQ3 2024open$8.80$24+168%
Point72 Asset ManagementQ3 2024Q1 2025$8.80$13+42%
Renaissance TechnologiesQ3 2024open$9.70$24+143%
Caveats
  • Covers only the 27 marquee funds tracked here, not the full institutional universe. A “0 holders” reading does not mean unowned.
  • Heavy funds (Renaissance Technologies, Citadel Advisors, Soros Fund Management, Two Sigma Investments, D.E. Shaw, AQR Capital Management, Millennium Management, Point72 Asset Management) use 8-quarter snapshots, so their pre-2024 history is missing.
  • “Current” reflects each fund's most recent 13F — filings lag the actual trade by up to 45 days; positions shown may have changed since.
  • Cost = price at the entry filing date. Re-entered positions show the most recent open lot.
  • Options, ADRs, and unmapped CUSIPs are excluded from the follower-backtest pipeline that produces these snapshots, so certain holding types won't appear here.